An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Saavedra, D; Ane-Kouri, AL; Sanchez, N; Filgueira, LM; Betancourt, J; Herrera, C; Manso, L; Chavez, E; Caballero, A; Hidalgo, C; Lorenzo, G; Cepeda, M; Valenzuela, C; Ramos, M; Leon, K; Mazorra, Z; Crombet, T

Saavedra, D (corresponding author), Ctr Mol Immunol, Dept Clin Immunol, 216 St,Corner 15,POB 16040, Havana, Atabey, Cuba.

IMMUNITY & AGEING, 2020; 17 (1):

Abstract

Background: Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around the world has been placed. In Cuba, the first case of......

Full Text Link